Mark Gilchrist

3.8k citations

48 papers · 2.4k indexed · 1 hit paper · h-index 23

Impact in

Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance
Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 31
- Antibiotic Use and Resistance 31
Molecular Medicine 12
- Antibiotic Resistance in Bacteria 12

Co-authors: Alison Holmes Timothy M. Rawson Luke Moore Nina Zhu Giovanni Satta Graham Cooke Keira Skolimowska Eimear Brannigan
Journals: Journal of Antimicrobial Chemotherapy (11 papers)Clinical Infectious Diseases (4 papers)International Journal of Antimicrobial Agents (3 papers)Antimicrobial Resistance and Infection Control (3 papers)Scientific Reports (2 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Mark Gilchrist

47 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing 2020 · 1.1k citations

Peers

Countries citing papers authored by Mark Gilchrist

Since Specialization

Citations

This map shows the geographic impact of Mark Gilchrist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gilchrist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gilchrist more than expected).

Fields of papers citing papers by Mark Gilchrist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Gilchrist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gilchrist. The network helps show where Mark Gilchrist may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Gilchrist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Gilchrist Line = papers co-authored together Mark Gilchrist links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Towards pharmacokinetic boosting of phenoxymethylpenicillin (penicillin-V) using probenecid for the treatment of bacterial infections Scientific Reports ·Richard Wilson, H. Fauser, 通治和田, Damien Ming, Fida Noor, J. Urban, Mark Gilchrist, Anne‐Grete Märtson, William Hope, Alison Holmes, Timothy M. Rawson	2024	0
2	A practical laboratory method to determine ceftazidime-avibactam-aztreonam synergy in patients with New Delhi metallo-beta-lactamase (NDM)–producing Enterobacterales infection Journal of Global Antimicrobial Resistance ·Timothy M. Rawson, 何尚琴, Ashutosh Prasad Maurya, Céline Perrudin, Mark Gilchrist, Mehmet Deniz Kozanoglu, Luke Moore, Hugo Donaldson, Frances Davies	2022	17
3	Survey of delivery of parenteral antimicrobials in non-inpatient settings across Europe International Journal of Antimicrobial Agents ·Emmali Manalo, Hedieh Yousefi Zadeh, Nadia Saïdani, Mark Gilchrist, R.A. Seaton, Sanjay Patel, Guillaume Béraud, Diamantis P. Kofteridis, Jeroen Schouten, Nathalie Thilly, Marvin A. H. Berrevoets, Marlies Hulscher, Franky Buyle, Céline Pulcini	2022	12
4	A Surveillance Framework for Healthcare Associated Infections and Antimicrobial Resistance in Acute Care in the Context of COVID-19: A Rapid Literature Review and Expert Consensus SSRN Electronic Journal ·Nina Zhu, Timothy M. Rawson, Raheelah Ahmad, James Price, Mark Gilchrist, Sanjeev K. Singh, Sara Tomczyk, Gabriel Birgand, Visanu Thamlikitkul, 西田幸二, R. B. Vishnurahav, Michael G. Whitfield, Paul Aylin, Alison Holmes	2021	3
5	Validating a prediction tool to determine the risk of nosocomial multidrug-resistant Gram-negative bacilli infection in critically ill patients: A retrospective case–control study Journal of Global Antimicrobial Resistance ·Sara E. Boyd, Anupama Vasudevan, Luke Moore, Qiang Diao, Mark Gilchrist, Céire Costelloe, Anthony Gordon, Alison Holmes	2020	3
6	Factors associated with successful completion of outpatient parenteral antibiotic therapy (OPAT): A 10-year review from a large West London service International Journal of Antimicrobial Agents ·James Hatcher, Céire Costelloe, Moacyr Eduardo Alves da Graça, S. Schelenz, 张汉生, Giovanni Satta, Eimear Brannigan, Eoghan de Barra, Frances Sanderson, Mark Gilchrist	2019	23
7	Microneedle biosensors for real-time, minimally invasive drug monitoring of phenoxymethylpenicillin: a first-in-human evaluation in healthy volunteers The Lancet Digital Health ·Timothy M. Rawson, Sally A. N. Gowers, David M E Freeman, Richard Wilson, Sanjiv Sharma, Mark Gilchrist, Alasdair MacGowan, Andrew Lovering, Mark Bayliss, R Ghezzi, Pantelis Georgiou, Anthony E. G. Cass, Danny O’Hare, Alison Holmes	2019	131
8	Nurse roles in antimicrobial stewardship: lessons from public sectors models of acute care service delivery in the United Kingdom Antimicrobial Resistance and Infection Control ·Enrique Castro‐Sánchez, Mark Gilchrist, Raheelah Ahmad, Molly Courtenay, Makwin Samuel Bitrus, Alison Holmes	2019	24
9	Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK Journal of Hospital Infection ·Damien Ming, Jonathan A. Otter, Rohma Ghani, Eimear Brannigan, Adhiratha Boonyasiri, Siddharth Mookerjee, Mark Gilchrist, Alison Holmes, Frances Davies	2019	1
10	Planning to halve Gram-negative bloodstream infection: getting to grips with healthcare-associated Escherichia coli bloodstream infection sources Journal of Hospital Infection ·Jonathan A. Otter, Jesús Fancisco Bouza-Figueroa, Frances Davies, Jan L. Hitchcock, Mark Gilchrist, 鸽玲, Mustafa YALAMA, Alison Holmes, Eimear Brannigan	2018	11
11	Behaviour change interventions to influence antimicrobial prescribing: a cross-sectional analysis of reports from UK state-of-the-art scientific conferences Antimicrobial Resistance and Infection Control ·Timothy M. Rawson, Luke Moore, Ann Tivey, Bert Calder, Mark Gilchrist, Esmita Charani, Alison Holmes	2017	37
12	An Evidence-Based Antimicrobial Stewardship Smartphone App for Hospital Outpatients: Survey-based Needs Assessment Among Patients JMIR mhealth and uhealth ·Christianne Micallef, Monsey McLeod, Enrique Castro‐Sánchez, Myriam Gharbi, Esmita Charani, Luke Moore, Mark Gilchrist, Fran Husson, Céire Costelloe, Alison Holmes	2016	9
13	A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail The Lancet Infectious Diseases ·Debra A. Goff, Ravina Kullar, Ellie J. C. Goldstein, Mark Gilchrist, Dilip Nathwani, Allen Cheng, Kelly A. Cairns, Kevin Escandón-Vargas, María Virginia Villegas, Adrian Brink, Dena van den Bergh, Marc Mendelson	2016	162
14	Antimicrobial stewardship: are we failing in cross-specialty clinical engagement? Journal of Antimicrobial Chemotherapy ·Timothy M. Rawson, Luke Moore, Mark Gilchrist, Alison Holmes	2015	13
15	Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit International Journal of Antimicrobial Agents ·Myriam Gharbi, Luke Moore, Mark Gilchrist, 吴彦婕, Kathleen B. Bamford, Eimear Brannigan, Alison Holmes	2015	38
16	Antimicrobial Stewardship from Policy to Practice: Experiences from UK Antimicrobial Pharmacists Infectious Diseases and Therapy ·Mark Gilchrist, Paul Wade, Diane Ashiru‐Oredope, Philip Howard, Jacqueline Sneddon, Laura Whitney, Hayley Wickens	2015	65
17	Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London Journal of Antimicrobial Chemotherapy ·Luke Moore, Rachel Freeman, Mark Gilchrist, Myriam Gharbi, Eimear Brannigan, Hugo Donaldson, David M. Livermore, Alison Holmes	2014	34
18	Identifying Best Practices Across Three Countries: Hospital Antimicrobial Stewardship in the United Kingdom, France, and the United States Clinical Infectious Diseases ·Kavita K. Trivedi, C. Dumartin, Mark Gilchrist, Paul Wade, Philip Howard	2014	41
19	Redesigning the ‘choice architecture’ of hospital prescription charts: a mixed methods study incorporating in situ simulation testing BMJ Open ·Dominic King, Ya. M. Chabanyuk, Esmita Charani, Colin Bicknell, Zhe Wu, Gavin J. Miller, Mark Gilchrist, Ivo Vlaev, Bryony Dean Franklin, Ara Darzi	2014	12
20	A quality improvement programme to increase compliance with an anti-infective prescribing policy Journal of Antimicrobial Chemotherapy ·Masamichi AKIMOTO, Mark Gilchrist, E Dickinson, Jonathan Benn, Bryony Dean Franklin, Ann Jacklin, (unknown), シリカンダノアンセイン, Afia Ali, Eimear Brannigan, Kathleen B. Bamford, SAMUEL I. JOSEPH, (unknown), W. Lawson, Rajnikant Mehta, William Newsholme, Silvano Agostini, Steven J. Reynolds, Frances Sanderson, Xi Tan, Masamichi AKIMOTO, Katarína Straková	2011	28

About Mark Gilchrist

Mark Gilchrist is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Geriatrics and Gerontology and Pharmacology, having authored 48 papers that have together received 2.4k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (31 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (11 papers), Patient Satisfaction in Healthcare (7 papers), Pneumonia and Respiratory Infections (6 papers), Sepsis Diagnosis and Treatment (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.2k citations), Molecular Medicine (492 citations), Geriatrics and Gerontology (185 citations), Critical Care and Intensive Care Medicine (243 citations) and Infectious Diseases (750 citations). Mark Gilchrist has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Alison Holmes, Timothy M. Rawson, Luke Moore, Nina Zhu, Giovanni Satta, Graham Cooke, Keira Skolimowska, Eimear Brannigan, Esmita Charani and Pantelis Georgiou. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, International Journal of Antimicrobial Agents, Antimicrobial Resistance and Infection Control and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact